Marcus Caballero

Isolated Components From Spider Venom Targeting Human Glioblastoma Cells and Its Potential Combined Therapy With Rapamycin

C. Rapôso, Marcus Caballero, N. Barreto, 2022, Frontiers in Molecular Biosciences.

Spider venom components decrease glioblastoma cell migration and invasion through RhoA-ROCK and Na+/K+-ATPase β2: potential molecular entities to treat invasive brain cancer

C. Rapôso, Marcus Caballero, N. Barreto, 2020, Cancer Cell International.

Spider venom administration impairs glioblastoma growth and modulates immune response in a non-clinical model

C. Rapôso, R. Thome, Marcus Caballero, 2020, Scientific Reports.